New EIU report challenges policy response to diabetes epidemic in the Gulf region
A new report released today entitled Diabetes in the Gulf: The policy challenge calls on policymakers in the Gulf region to do more to address the growing challenge of diabetes. The report, developed by The Economist Intelligence Unit (EIU) and sponsored by Janssen, highlights the sharp rise in prevalence of diabetes and the associated rising economic costs and calls for a coherent region-wide approach to tackle the issue.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151113005348/en/
Diabetes is a ticking time bomb in the Gulf region. Data from the International Diabetes Federation (IDF) shows that prevalence of the disease has reached 23.9% of the adult population in Saudi Arabia, 23.1% in Kuwait and 19.8% Qatar, over twice the global average of 8.3%. Overweight and obesity, brought on by rising economic prosperity, are to blame for driving the diabetes epidemic in this region, with up to 75% of adults and up to 40% of under-18s overweight or obese.
Consequently, the financial burden of diabetes in the region is high and has the potential to rise even further. The report notes that US$16.8bn was spent on diabetes care in 2014, according to estimates from the IDF, with this figure set to rise to US$24.7bn by 2035. Additionally, as people develop diabetes at a younger age, a growing number of patients are living with the disease for longer, significantly increasing the per-capita costs of patient care.
With healthcare investment in the Gulf region ranging from 2.2% to 4.9% of GDP in 2012, far below the OECD average of 8.9% of GDP, there is significant scope to increase healthcare investment levels in this region. However, it is important to note that it is not just about the amount of money spent on dealing with diabetes, but how this money is invested. The report highlights that while several initiatives are being implemented in the Gulf region, including those targeting specific aspects of the disease such as screening, the response is not consistent throughout the region.
“Our research has revealed a number of opportunities to help combat the rise of diabetes in Gulf region,” said Martin Koehring, report editor, EIU. “From strengthening primary healthcare, to introducing tough new legislation and engaging community leaders, policymakers must adopt regional practices to tackle the growing burden of diabetes in the Gulf.”
“The rise of diabetes in the Gulf region is a significant public health concern and represents a substantial risk to further development,” said Jane Griffiths, Company Group Chairman, Janssen Europe, the Middle East and Africa (EMEA). “Janssen is committed to investing in local and regional initiatives to help tackle the burden of diabetes in the region. We hope this report will offer valuable insights into the burden of the disease and encourage change in how policymakers combat the disease.”
The Diabetes in the Gulf: The policy challenge report can be read online at: http://www.janssen-emea.com/node/1379
NOTES TO EDITORS
About the Diabetes in the Gulf: The policy challenge report
Diabetes in the Gulf: The policy challenge is an Economist Intelligence Unit report, sponsored by Janssen. It assesses the current status and potential impact of diabetes in the six Gulf Co-operation Council states—Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and the UAE; reviews current approaches to tackling the disease in the region; and explores further possible opportunities to help combat diabetes. In this report, diabetes refers to type 2 diabetes.
In July-August 2015 The Economist Intelligence Unit (EIU) conducted 18 interviews with experts on diabetes in the Gulf region, including policymakers, policy advisers, academics and health practitioners. The insights from these in-depth interviews appear throughout the report.
About The Economist Intelligence Unit
The Economist Intelligence Unit (EIU) is the world leader in global business intelligence. It is the business-to-business arm of The Economist Group, which publishes The Economist newspaper. The EIU helps executives make better decisions by providing timely, reliable and impartial analysis on worldwide market trends and business strategies. More information can be found at www.eiu.com or www.twitter.com/theeiu .
Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology (e.g. multiple myeloma and prostate cancer), immunology (e.g. psoriasis), neuroscience (e.g. schizophrenia, dementia and pain), infectious disease (e.g. HIV/AIDS, hepatitis C and tuberculosis), and cardiovascular and metabolic diseases (e.g. diabetes). For more information, please visit www.janssen.com .
# # #
T:+33 1 55 00 40 66
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
UNIPRINT.NET19.7.2018 09:37 | pressemeddelelse
Pat Johnson Joins UniPrint Team in Europe
POSEIDON-FOUNDATION19.7.2018 09:36 | pressemeddelelse
The Poseidon Foundation: Liverpool Bids to Be First ‘Climate Positive’ City by End of 2020
ELLIOTT-ADVISORS-(UK)19.7.2018 09:32 | pressemeddelelse
Elliott Advisors (UK) Statement on thyssenkrupp AG
FLEXTRADE19.7.2018 09:32 | pressemeddelelse
Albar Capital Deploys FlexNOW
MA-LOGIN-VSI19.7.2018 08:37 | pressemeddelelse
Login VSI Revolutionizes Application Compatibility Testing
TAKEDA-PHARMACEUTICAL19.7.2018 07:02 | pressemeddelelse
New Phase 3 Data Show Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum